TRIESENCE

This brand name is authorized in Canada, Finland, Spain, United States.

Active ingredients

The drug TRIESENCE contains one active pharmaceutical ingredient (API):

1	Triamcinolone UNII F446C597KA - TRIAMCINOLONE ACETONIDE
	Triamcinolone acetonide is a more potent derivative of triamcinolone and is approximately 8 times more potent than prednisone. Although the precise mechanism of corticosteroid anti-allergic action is unknown, corticosteroids are very effective in the treatment of allergic diseases in man. Also, local injections are thought to have an anti-inflammatory effect.
	Read more about Triamcinolone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01BA05	Triamcinolone	S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BA Corticosteroids, plain
Discover more medicines within S01BA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02368676
ES	Centro de información online de medicamentos de la AEMPS	74673
FI	Lääkealan turvallisuus- ja kehittämiskeskus	412915
US	FDA, National Drug Code	0065-0543